PD-L1 expression within primary tumours: 58% negative, 42% positive (34% moderately positive, 8% strongly positive)PD-L1 expression within metastatic site: 54% negative, 46% positive (38% moderately positive, 8% strongly positive). This evidence concerns the gene CD274 and neoplasm.